| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 27, 1261-1263, Copyright © 1981 by American Association for Clinical Chemistry
DM Nathan
The utility of glycosylated hemoglobin (HbA1) measurement as an index of chronic control in diabetes can be adversely affected by interference from a labile glycosylated fraction that changes rapidly with acute changes in blood glucose concentration. I used a "high- pressure" liquid-chromatographic assay and a newly developed electrophoretic assay to quantitate the contribution of this labile fraction. If erythrocytes are incubated at 22 degrees C in isotonic saline for 12 h before hemolysis, the labile fraction is eliminated. Its contribution is similar as measured by both assays: 2-3.5% of total HbA1 in normal cells and 7-9.5% in diabetic cells. A 3-h incubation of erythrocytes with glucose produces acute changes in apparent HbA1 concentrations by both assays, but such changes can be eliminated by the incubation in saline. Although current methods are time consuming, the labile glycosylated hemoglobin must be removed when the sample is prepared for HbA1 measurement by liquid chromatography and electrophoresis if results are not to be factitiously high.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  M.-F. Hivert, A. K. Manning, J. B. McAteer, J. Dupuis, C. S. Fox, L. A. Cupples, J. B. Meigs, and J. C. Florez Association of Variants in RETN With Plasma Resistin Levels and Diabetes-Related Traits in the Framingham Offspring Study Diabetes, March 1, 2009; 58(3): 750 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. N. Pani, D. M. Nathan, and R. W. Grant Clinical Predictors of Disease Progression and Medication Initiation in Untreated Patients With Type 2 Diabetes and A1C Less Than 7% Diabetes Care, March 1, 2008; 31(3): 386 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Henderson, P. M. Copeland, T. B. Daley, C. P. Borba, C. Cather, D. D. Nguyen, P. M. Louie, A. E. Evins, O. Freudenreich, D. Hayden, et al. A Double-Blind, Placebo-Controlled Trial of Sibutramine for Olanzapine-Associated Weight Gain Am J Psychiatry, May 1, 2005; 162(5): 954 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs, C. I. M. Panhuysen, R. H. Myers, P. W.F. Wilson, and L. A. Cupples A Genome-Wide Scan for Loci Linked to Plasma Levels of Glucose and HbA1c in a Community-Based Sample of Caucasian Pedigrees: The Framingham Offspring Study Diabetes, March 1, 2002; 51(3): 833 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Galluzzi, L. A. Cupples, J. B. Meigs, P. W.F. Wilson, E. J. Schaefer, and J. M. Ordovas Association of the Ala54-thr Polymorphism in the Intestinal Fatty Acid-Binding Protein With 2-h Postchallenge Insulin Levels in the Framingham Offspring Study Diabetes Care, July 1, 2001; 24(7): 1161 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Meigs, M. A. Mittleman, D. M. Nathan, G. H. Tofler, D. E. Singer, P. M. Murphy-Sheehy, I. Lipinska, R. B. D'Agostino, and P. W. F. Wilson Hyperinsulinemia, Hyperglycemia, and Impaired Hemostasis: The Framingham Offspring Study JAMA, January 12, 2000; 283(2): 221 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Singer, C. M. Coley, J. H. Samet, and D. M. Nathan Tests of Glycemia in Diabetes Mellitus: Their Use in Establishing a Diagnosis and in Treatment Ann Intern Med, January 15, 1989; 110(2): 125 - 137. [Abstract] [PDF]
|
|
|
|
|
|
D. M. NATHAN, A. ROUSSELL, and J. E. GODINE Glyburide or Insulin for Metabolic Control in Non-Insulin-Dependent Diabetes Mellitus: A Randomized, Double-Blind Study Ann Intern Med, March 1, 1988; 108(3): 334 - 340. [Abstract] [PDF]
|
|
|
|
|
|
D. M. NATHAN, P. LOU, and J. AVRUCH Intensive Conventional and Insulin Pump Therapies in Adult Type I Diabetes: A Crossover Study Ann Intern Med, July 1, 1982; 97(1): 31 - 36. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
